Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	223.82M +9.2%
Revenue (ttm)	330.34M -1.0%
Net Income	4.25M -55.5%
EPS	0.05
Shares Out	81.39M
PE Ratio	52.66
Forward PE	91.67
Dividend	0.05 (1.78%)
Ex-Dividend Date	May 15, 2025

Volume	813
Average Volume	24,595
Open	2.730
Previous Close	2.750
Day's Range	2.730 - 2.760
52-Week Range	2.500 - 3.400
Beta	0.99
RSI	58.25
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,426
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.